- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bang for the Buck: How Health Care Innovation Affects Life Expectancy and Patient Well-Being
During a webinar, experts discussed where health care has improved life expectancy and the relationship between cost and relative contribution that each area makes to life improvement and expectancy.
During a 60-minute discussion, the speakers on The American Journal of Managed Care® webinar "Bang for the Buck: How Health Care Innovation Affects Life Expectancy and Patient Well-Being" highlighted where health care has improved life expectancy and which areas (public health, drugs, hospital care, surgery, devices, etc.) have contributed the most.
The speakers framed the discussion around 3 papers published in the last year abut the connection between health care spending and value creation.
Robert W. Dubois, MD, PhD, interim president and CEO of the National Pharmaceutical Council, moderated the discussion with:
- Mariam Alboustani, RPh, clinical pharmacy manager, Medicare Pharmacy Services, Blue Cross Blue Shield of Michigan
- Jason Buxbaum, MHSA, PhD candidate, program in health policy, Harvard University
- Michael Ciarametaro, MBA, vice president of research, National Pharmaceutical Council
- David Cutler, PhD, Otto Eckstein Professor of Applied Economics, Harvard University
Let us know what you thought of the webinar and take our short survey.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
